Investment
Features
FeesSafety
Academy
More
Pluang+

Compare YieldMax MSTR Option Income Strategy ETF (MSTY) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance

YieldMax MSTR Option Income Strategy ETFTrade
Relay Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

YieldMax MSTR Option Income Strategy ETF vs Relay Therapeutics Inc. Common Stock — how do they compare? YieldMax MSTR Option Income Strategy ETF trades at $15.78 (market cap $1.11B), while Relay Therapeutics Inc. Common Stock trades at $17.5 (market cap $3.94B). The key difference: Relay Therapeutics Inc. Common Stock is far larger — about 3.5× YieldMax MSTR Option Income Strategy ETF's market cap, and Relay Therapeutics Inc. Common Stock is trading nearer its 52-week high, YieldMax MSTR Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold YieldMax MSTR Option Income Strategy ETF for 30 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.

MSTYRLAY
Market Cap
$1.11B$3.94B
Volume
3,805,3843,432,928
Sector
Income / Options OverlayHealth
52-Week High
$67.85$20.75
52-Week Low
$11.55$6.03
Typical Hold Time
30 Days0 Days
Enterprise Value
—$3.06B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

YieldMax MSTR Option Income Strategy ETF

MSTY, the YieldMax MSTR Option Income Strategy ETF, trades at $15.83, down 5.61% with a bearish technical signal. The fund generates weekly distributions through options strategies on MicroStrategy stock, with recent payouts ranging from $0.16 to $0.34. Despite high distribution rates exceeding 100% annualized, the fund has experienced significant NAV erosion, declining approximately 34% over six months according to 24/7 Wall Street analysis from July 2026.

The outlook remains challenging as MSTY's strategy sacrifices capital appreciation for income generation. While the high distribution rate provides income, the structural erosion of NAV presents substantial risk. Investors face the dual challenge of receiving taxable distributions while experiencing principal decline, making this suitable only for those prioritizing current income over capital preservation.

Relay Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MSTY
83% Buy17% Sell
Avg holding period · 30 Days
RLAY
100% Buy0% Sell
Avg holding period · 0 Days

About YieldMax MSTR Option Income Strategy ETF

MSTY is an actively managed ETF that pursues a synthetic covered call strategy on MicroStrategy Incorporated (MSTR) stock. The fund primarily sells call options on MSTR and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the volatile, Bitcoin-correlated growth potential of MSTR while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.

Read more on MSTY →

About Relay Therapeutics Inc. Common Stock

Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.

Read more on RLAY →